A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Clinical trial NCT04552977 · UNKNOWN
Trial details
- NCT number
- NCT04552977
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2021-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.